Asset Dedication’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Asset Dedication's XBI Position: Q3 2026 in Review
Asset Dedication increased its State Street SPDR S&P Biotech ETF (XBI) stake by 240% in Q3 2026, buying an estimated $5.68K and bringing the position to 51 shares worth $8.04K. The position accounts for ﹤0.01% of the portfolio, ranked #827.
Asset Dedication first reported a position in XBI in Q1 2019 and has held it in 4 quarters since. The position peaked at $41K in Q1 2019. 820 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Asset Dedication held 51 shares of State Street SPDR S&P Biotech ETF worth $8.04K as of Q3 2026.
- Asset Dedication bought 36 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $5.68K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #827 holding.
- Asset Dedication first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and has held it in 4 quarters since.
- Asset Dedication's State Street SPDR S&P Biotech ETF position peaked at $41K in Q1 2019.
- 820 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.